Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 575
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02131207 | MRI Before Biopsy in Diagnosing Patients With Prostate Cancer | ||
| NCT00970684 | Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | ||
| NCT06447376 | Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab | ||
| NCT03290417 | Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer | ||
| NCT03818776 | Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC | ||
| NCT05142358 | A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose | ||
| NCT06698744 | UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT01839955 | Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer | ||
| NCT02948712 | Adolescent and Young Adult Survivor Transition | ||
| NCT01658319 | Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies | ||
| NCT04741256 | Implementation of a Standardized Tracheostomy Education Discharge Protocol | ||
| NCT00005822 | SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | ||
| NCT05400109 | Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas | ||
| NCT02987998 | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC | ||
| NCT07219472 | Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy | ||
| NCT04285749 | Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas | ||
| NCT01593384 | Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography | ||
| NCT00006255 | Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases | ||
| NCT02846935 | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies | ||
| NCT02613923 | A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer | ||
| NCT00278148 | Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer | ||
| NCT00527293 | Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer | ||
| NCT02681614 | Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning | ||
| NCT07114614 | Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors | ||
| NCT00530751 | Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation | ||
| NCT04713241 | Acupuncture for the Treatment of Postoperative Ileus After Gastrointestinal Surgery | ||
| NCT05590624 | Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer | ||
| NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | ||
| NCT04140292 | Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses | ||
| NCT04010357 | Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC | ||
| NCT02071901 | Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy | ||
| NCT00021151 | Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT05013437 | Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma | ||
| NCT01959490 | Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer | ||
| NCT06738303 | Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer | ||
| NCT00074204 | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT04059757 | Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD | ||
| NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | ||
| NCT02128373 | A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer | ||
| NCT01783522 | Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib | ||
| NCT05333029 | Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD | ||
| NCT00003928 | Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer | ||
| NCT04545177 | Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue | ||
| NCT00509093 | Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy | ||
| NCT04245150 | Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity | ||
| NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | ||
| NCT07241585 | Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) | ||
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | ||
| NCT01083368 | Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy | ||
| NCT00947388 | Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) |
